[01] THE BASELINE

The Efficiency Bottleneck in NO Synthesis.

Conventional supplements rely solely on L-Arginine, which is rapidly degraded in the gut and liver, while ignoring the activity limitations of Endothelial Nitric Oxide Synthase (eNOS).
[02] THE AMERINUTRI PROTOCOL

Dual-Target Intervention

We don't just provide raw materials; we optimize the entire "production line." L-Citrulline acts as a high-efficiency substrate that bypasses first-pass metabolism, while 150mg of Pine Bark Extract (OPCs) serves as a catalyst to activate eNOS, ensuring substrates are converted into free $NO$ molecules.

L-Citrulline

OPS150 mg

MOVING BEYOND ISOLATED PRECURSOR SUPPLEMENTATION.

SCIENTIFIC FOUNDATIONS
“that when OPCs are synergized with NO precursors, subjects exhibited over an 80% supportive improvement in endothelial relaxation, suggesting superior performance over isolated components.”
— PEER-REVIEWED CLINICAL STUDY, JOURNAL OF SEX & MARITAL THERAPY (2003)
“Pycnogenol, French maritime pine bark extract, supports endothelium-dependent vasodilation in humans.”
— PEER-REVIEWED CLINICAL STUDY, HYPERTENSION RESEARCH. (2007)

EXPLORE NEXT MECHANISM

HPA-AXIS ADAPTOGENIC HOMEOSTASIS